LATE-BREAKING ABSTRACT: TRINITY: A phase III study to compare the efficacy and safety of an extrafine triple combination of beclometasone dipropionate (BDP), formoterol fumarate (FF), and glycopyrronium bromide (GB) pMDI (CHF5993) with tiotropium (Tio) and a free triple combination of BDP/FF (Foster®) + Tio in COPD patients
Keyword(s):
2016 ◽
Keyword(s):
Keyword(s):
2018 ◽
Vol 25
(6)
◽
pp. e609-e616
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):